SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-025191
Filing Date
2018-09-25
Accepted
2018-09-25 18:04:25
Documents
2
Period of Report
2018-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1698
2 EX-24 DOCUMENT attachment1.htm EX-24 3285
  Complete submission text file 0000899243-18-025191.txt   6548
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1650 TYSONS BOULEVARD SUITE 1700 MCLEAN VA 22102
Business Address
Milligan Peter J (Reporting) CIK: 0001531049 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 181086509